Physician profile
Seing Houy
NPI 1639218985
$2,099.79
in general payments reported to CMS, 2019-2025
9 companies · $86.11 in 2025
The $86.11 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $1,071 · 2023: $561 · 2024: $173 · 2025: $86.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $747.91 | 2021-2024 | Hawkone, Symplicity G3, Micra |
| Boston Scientific Corporation | $637.51 | 2021-2025 | Rotapro, Avvigo Guidance System, Opticross |
| Tactile Systems Technology INC | $268.39 | 2022 | |
| Abbott Laboratories | $196.80 | 2022-2025 | Jot Dx, Aveir |
| Csl Behring | $124.99 | 2022 | |
| Chiesi USA, INC. | $39.76 | 2021-2022 | |
| Shockwave Medical, INC | $35.29 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $28.53 | 2025 | Penumbra System |
| Astrazeneca Pharmaceuticals LP | $20.61 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seing Houy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.